Grants paid by Laygend Foundation
EIN 87-2737376 · Rcho Santa Fe, CA · Form 990-PF, Part XV · NTEE T20
Laygend Foundation of Rcho Santa Fe, CA (EIN 87-2737376) reported 6 grants paid totaling $28,740,000 to 4 recipients in tax years 2022–2024, on Form 990-PF, Part XV. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$28,740,000
6 grants
Recipients
4
distinct organizations
Tax years
2022–2024
3 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2022 | 1 | $2,500,000 | — |
| 2023 | 2 | $7,500,000 | — |
| 2024 | 3 | $18,740,000 | — |
Top recipients
The 4 recipients receiving the most from Laygend Foundation, by grants paid, out of 4 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Harvard Brigham and Women Hospital | U | Boston, MA | 1 | $11,240,000 | 2024 |
| Regents of University of California | U | La Jolla, CA | 3 | $7,500,000 | 2024 |
| Havard Brigham and Woman Hospital | U | Boston, MA | 1 | $5,000,000 | 2023 |
| Washington University 52-1538367 | B | St Louis, MO | 1 | $5,000,000 | 2024 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 6 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2024 | Harvard Brigham and Women Hospital Boston, MA | U | $11,240,000 | paid | GENERAL | 202513179349102386 |
| 2024 | Washington University St Louis, MO | B | $5,000,000 | paid | GENERAL | 202513179349102386 |
| 2024 | Regents of University of California La Jolla, CA | U | $2,500,000 | paid | GENERAL | 202513179349102386 |
| 2023 | Havard Brigham and Woman Hospital Boston, MA | U | $5,000,000 | paid | Laygend Foundation established Gene Lay Institute of Immunology and Inflammation in May 2023 and pledged an endowment fund in supporting and empowering multi-institution team and collective efforts of Brigham & Woman Hospital, Massachusetts General Hospital and Harvard Medical School for research activities in the areas of immunology and Inflammation and translate research discovery into therapies and bring solutions to patients and families. The primary areas of research will include basic understanding of immune-mediated diseases, aging, and cancer and translation of this knowledge to the development of new immunotherapies and build new knowledge to promote basic understanding for preventing and treating immune-mediated diseases. In addition, the Gene Lay Institute will provide substantial training opportunities for students and fellows to support immunology innovators of the future. | 202442609349100319 |
| 2023 | Regents of University of California La Jolla, CA | U | $2,500,000 | paid | Postsecondary Education:The endowment will build on the UCSD's Department of Bioengineering excellence by providing transformative annual recurring support for research and education. Collectively, this funding will be critical for the department's efforts to bridge gaps between bioengineering research and clinical impacts that directly improve human health. | 202442609349100319 |
| 2022 | Regents of University of California La Jolla, CA | U | $2,500,000 | paid | Postsecondary Education:The endowment will build on the UCSD's Department of Bioengineering excellence by providing transformative annual recurring support for research and education. Collectively, this funding will be critical for the department's efforts to bridge gaps between bioengineering research and clinical impacts that directly improve human health. | 202323109349101062 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990PF | 2024 | 2024-12-31 | not stated | 2024v5.2 | 202513179349102386 |
| 990PF | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202442609349100319 |
| 990PF | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202323109349101062 |
Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/872737376.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.